Medtronic launches GI Genius in US as first AI system for colonoscopy

Medtronic on Monday announced the US launch of its GI Genius intelligent endoscopy module, which garnered FDA de novo clearance late last week, making it the first commercially available computer-aided detection system using artificial intelligence (AI) to identify colorectal polyps. Medtronic is the exclusive worldwide distributor of GI Genius, which was developed and is manufactured by Cosmo Artificial Intelligence.

Giovanni Di Napoli, president of Medtronic's gastrointestinal business, remarked that "by introducing AI technology into the colonoscopy market, we anticipate improving colonoscopy detection rates and reducing variability in patient outcomes." The company estimated that GI Genius has the potential to address 19 million screening colonoscopies in the US every year.

14% increase in adenoma detection rate

Medtronic said the module, which is compatible with any colonoscope video, serves as "an ever vigilant second observer" by using AI technology to highlight the presence of precancerous lesions with a visual marker in real-time. GI Genius processes images using advanced algorithms that can identify and mark abnormalities consistent with polyps, including small flat polyps that might otherwise go undetected by the human eye. According to the company, use of GI Genius has shown a 14% absolute increase in adenoma detection rate, compared with colonoscopy alone, for both flat and polypoid lesions.

The GI Genius module is also available in Europe and select markets in Asia, Australia and the Middle East, including Israel and the United Arab Emirates

To ensure you don't miss other Top Stories like these and news on key healthtech industry developments, sign up for our free daily e-newsletter here.  

Did you like this article?